- Report
- September 2024
- 363 Pages
Global
From €5076EUR$5,450USD£4,224GBP
- Report
- January 2024
- 200 Pages
Global
From €3865EUR$4,150USD£3,217GBP
- Report
- March 2024
- 188 Pages
Global
From €3669EUR$3,939USD£3,053GBP
- Report
- March 2024
- 197 Pages
Global
From €3669EUR$3,939USD£3,053GBP
- Report
- September 2024
Global
From €5029EUR$5,400USD£4,186GBP
- Report
- September 2024
- 281 Pages
Global
From €5216EUR$5,600USD£4,341GBP
- Report
- January 2024
- 110 Pages
Global
From €5542EUR$5,950USD£4,612GBP
- Report
- September 2024
- 175 Pages
Global
From €4657EUR$5,000USD£3,876GBP
- Report
- September 2024
- 194 Pages
Global
From €4610EUR$4,950USD£3,837GBP
- Report
- June 2024
- 178 Pages
Global
From €2328EUR$2,500USD£1,938GBP
- Report
- August 2024
- 175 Pages
Global
From €4657EUR$5,000USD£3,876GBP
- Report
- January 2024
- 200 Pages
Global
From €3726EUR$4,000USD£3,100GBP
- Report
- January 2024
- 200 Pages
Global
From €3726EUR$4,000USD£3,100GBP
- Report
- February 2024
- 190 Pages
Global
From €4564EUR$4,900USD£3,798GBP
- Report
- June 2024
- 80 Pages
United States
From €3679EUR$3,950USD£3,062GBP
- Report
- January 2023
- 197 Pages
Global
From €4912EUR$5,459USD£3,950GBP
- Report
- March 2022
- 120 Pages
Global
From €2328EUR$2,500USD£1,938GBP
- Report
- May 2023
- 84 Pages
Global
From €3500EUR$4,026USD£3,015GBP
- Report
- April 2023
- 90 Pages
Global
From €4424EUR$4,750USD£3,682GBP
- Report
- November 2021
- 90 Pages
Global
From €4191EUR$4,500USD£3,488GBP
The Biodefense market is a sector of the biotechnology industry that focuses on the development of products and services to protect against biological threats. This includes the development of vaccines, diagnostics, and treatments for infectious diseases, as well as the development of countermeasures to protect against bioterrorism. Biodefense products are designed to protect against a wide range of biological agents, including bacteria, viruses, and toxins.
The Biodefense market is driven by the need to protect against the increasing threat of biological agents, as well as the need to develop treatments for existing and emerging infectious diseases. Governments, healthcare organizations, and private companies are investing in the development of biodefense products and services.
Some of the major companies in the Biodefense market include Emergent BioSolutions, GlaxoSmithKline, Johnson & Johnson, Merck, Novavax, Pfizer, and Sanofi. These companies are developing a range of products and services to protect against biological threats, including vaccines, diagnostics, and treatments. Show Less Read more